Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Immunosuppression sparing in patient with severe sepsis post renal transplant

K Kotfïs, M Zukowski, J Biernawska, M Zegan, R Bohatyrewicz, A Greczan

Ann Transplant 2009; 14(1): 75-75 :: ID: 880476

Abstract

Background: In patients after a renal transplant, life-long immunosuppression is a part of absolutely required treatment to prevent acute graft rejection. Faced with severe infection or impending sepsis the immunosuppression further complicates treatment, especially in case of sepsis-induced secondary immunosuppression.
Case Report: We present a case of a 57-year old female (with h/o autosomal
dominant polycystic kidney disease, hypertension, secondary diabetes mellitus, end-stage chronic renal disease, post bilateral nephrectomy) who was admitted to ICU 2 months after a renal transplant with severe respiratory failure secondary to pneumonia. She subsequently developed septic shock with neutropenia. Routine microbiological screening showed E.coli ESBL (+) growth, patient was treated according to microbiology sensitivity. The immunosuppressive agents (tacrolimus, corticosteroids) were continued throughout the course of treatment to prevent acute graft rejection, mycophenolate mofetil was discontinued on admission to ICU. Despite multimodal approach (including HVCVVH, drotrecogin alfa infusion) patient died on the 4th day after admission (cardiac arrest, asystole).
Conclusions: Net state of immunosuppression is achieved as a balance between exposure to infectious agents (hospital or community sources) and overall immunosuppression level. This case raises one important issue. A question of the timing and extent of immunosuppression withdrawal: at the
diagnosis of severe infection, when the diagnosis of sepsis is made or when
neutropenia occurs in the course of sepsis?

Keywords: Immunosuppression, Kidney Transplantation

Add Comment 0 Comments

In Press

06 Feb 2024 : Case report  

Successful Sequential Liver and Isolated Intestine Transplantation for Mitochondrial Neurogastrointestinal ...

Ann Transplant In Press; DOI: 10.12659/AOT.941881  

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358